• Je něco špatně v tomto záznamu ?

Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube

A. Papiez, K. Odehnalova, V. Sramek, P. Suk,

. 2019 ; 103 (5-6) : 246-249. [pub] 20190206

Jazyk angličtina Země Švýcarsko

Typ dokumentu srovnávací studie, zprávy, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027847

BACKGROUND/AIMS: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. METHODS: A film-coated tablet (FilmCT) containing clopidogrel (Trombex®) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc®) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). RESULTS: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 ± 4.2 and 10.7 ± 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 ± 7.2 vs. 2.0 ± 4.2%; p < 0.001) or FilmCT (14.1 ± 2.2 vs. 7.7 ± 4.1%; p < 0.01). CONCLUSION: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027847
003      
CZ-PrNML
005      
20190822091531.0
007      
ta
008      
190813s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000496423 $2 doi
035    __
$a (PubMed)30726848
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Papiez, Adriana $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    10
$a Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube / $c A. Papiez, K. Odehnalova, V. Sramek, P. Suk,
520    9_
$a BACKGROUND/AIMS: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. METHODS: A film-coated tablet (FilmCT) containing clopidogrel (Trombex®) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc®) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). RESULTS: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 ± 4.2 and 10.7 ± 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 ± 7.2 vs. 2.0 ± 4.2%; p < 0.001) or FilmCT (14.1 ± 2.2 vs. 7.7 ± 4.1%; p < 0.01). CONCLUSION: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a klopidogrel $x aplikace a dávkování $x chemie $7 D000077144
650    _2
$a enterální výživa $x přístrojové vybavení $7 D004750
650    12
$a gastrointestinální intubace $7 D007441
650    _2
$a pantoprazol $x aplikace a dávkování $x chemie $7 D000077402
650    _2
$a spektrofotometrie ultrafialová $x metody $7 D013056
650    _2
$a tablety $7 D013607
650    _2
$a enterosolventní tablety $7 D013608
655    _2
$a srovnávací studie $7 D003160
655    _2
$a zprávy $7 D016433
655    _2
$a validační studie $7 D023361
700    1_
$a Odehnalova, Klara $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
700    1_
$a Sramek, Vladimir $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Suk, Pavel $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic, pavel.suk@fnusa.cz. Faculty of Medicine, Masaryk University, Brno, Czech Republic, pavel.suk@fnusa.cz.
773    0_
$w MED00003791 $t Pharmacology $x 1423-0313 $g Roč. 103, č. 5-6 (2019), s. 246-249
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30726848 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822091809 $b ABA008
999    __
$a ok $b bmc $g 1432996 $s 1066307
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 103 $c 5-6 $d 246-249 $e 20190206 $i 1423-0313 $m Pharmacology $n Pharmacology $x MED00003791
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...